BJ
SRPT icon

BlackRock Japan’s Sarepta Therapeutics SRPT Stock Holding History

BlackRock Japan’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$22K Buy
791
+330
+72% +$13.3K ﹤0.01% 1106
2016
Q3 		$28K Buy
461
+276
+149% +$8.34K ﹤0.01% 1065
2016
Q2 		$4K Hold
185
– – ﹤0.01% 1361
2016
Q1 		$4K Sell
185
-328
-64% -$5.73K ﹤0.01% 1378
2015
Q4 		$20K Buy
513
+176
+52% +$5.71K ﹤0.01% 1159
2015
Q3 		$11K Buy
337
+148
+78% +$5.02K ﹤0.01% 1158
2015
Q2 		$6K Buy
+189
New +$3.87K ﹤0.01% 1300
2014
Q3 		– Sell
-3,246
Closed -$97K – 1307
2014
Q2 		$97K Buy
+3,246
New +$103K ﹤0.01% 940

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock Japan's SRPT Position: Q4 2016 in Review

BlackRock Japan increased its Sarepta Therapeutics (SRPT) stake by 72% in Q4 2016, buying an estimated $13.3K and bringing the position to 791 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #1106.

BlackRock Japan first reported a position in SRPT in Q2 2014 and has held it in 8 quarters since. The position peaked at $97K in Q2 2014. 178 funds tracked by Wall St. Rank hold SRPT as of Q4 2016.

  • BlackRock Japan held 791 shares of Sarepta Therapeutics worth $22K as of Q4 2016.
  • BlackRock Japan bought 330 Sarepta Therapeutics shares in Q4 2016, an estimated $13.3K.
  • Sarepta Therapeutics made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1106 holding.
  • BlackRock Japan first reported a position in Sarepta Therapeutics in Q2 2014 and has held it in 8 quarters since.
  • BlackRock Japan's Sarepta Therapeutics position peaked at $97K in Q2 2014.
  • 178 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.